Ligand Pharmaceuticals Incorporated【LGND】 業績推移・財務諸表

(単位:千ドル) 2011/12 2012/12 2013/12 2014/12 2015/12 2016/12 2017/12 2018/12 2019/12 2020/12 2021/12 2022/12 2023/12 2024/12
売上高 30,037 31,388 48,973 64,538 71,914 108,973 141,102 251,453 120,282 186,419 277,133 196,245 131,314 167,133
売上成長率(%) - 54.98 48.66 -29.19 -33.09 27.28
売上原価 4,909 3,601 5,732 9,136 5,807 5,571 5,366 6,337 11,347 30,419 62,176 52,827 10,512 11,074
研究開発費 10,291 10,790 9,274 12,122 13,380 21,221 26,887 27,863 55,908 59,392 69,012 36,082 24,537 21,425
営業利益 -698 574 14,943 19,626 27,329 43,885 68,076 163,727 807,076 25,845 78,895 3,037 11,942 -22,606
営業利益率 (%) 13.86 28.47 1.55 9.09 -13.53
経常(税引前)利益 -2,952 -3,865 9,206 11,302 35,329 7,960 57,231 173,330 796,639 -10,538 47,298 36,011 63,660 2,518
経常(税引前)利益率(%) -9.83 -12.31 18.8 17.51 49.13 7.3 40.56 68.93 662.31 -5.65 17.07 18.35 48.48 1.51
法人税等合計 -13,125 - 374 410 -219,596 10,327 44,675 30,009 167,337 -7,553 -9,840 41,230 9,841 6,550
実効税率(%) - 0 0 0 0 0
純利益 10,176 -527 11,420 12,024 257,305 -1,636 12,556 143,321 629,302 -2,985 57,138 -33,361 52,154 -4,032
純利益率(%) -1.6 20.62 -17.0 39.72 -2.41
一株あたり利益 - - 0.56 0.59 13 -0.08 0.6 6.77 33.13 -0.18 3.44 -1.98 3.02 -0.22
希薄化後一株あたり利益 - - 0.55 0.56 12.12 -0.08 0.53 5.96 31.85 -0.18 3.31 -1.98 2.94 -0.22
EBITDA 51,536 129,966 54,571 48,463 12,633
EBITDAマージン(%) 27.65 46.9 27.81 36.91 7.56